搜索到 1000 条关于 마산오피✐sgbusan、coм 마산풀싸롱 마산출장마사지❅마산오피 마산키스방●마산스포츠마사지 的文章

HBV, HCV/HIV Coinfection

2011.12.28 HBV, HCV/HIV Coinfection

;Influence of HIV on HBV-17HIV Co-infection Increases...;HCV HIV Co-infection-37Worldwide prevalence of HCV

2008.08.29 29日下午第二主会场:第二届海峡两岸临床肿瘤学新进展研讨会

教授执行主席(Co-Chairs):吴一龙 教授 郑安理 教授特邀嘉宾(Guests):罗永章 教授 叶坤辉 教授 

2008.08.29 29日下午第三主会场:分子靶向治疗专题论坛

芸 教授执行主席(Co-Chairs):任 军 教授 徐瑞华 教授特邀嘉宾(Guests):Prof. Jean Yves

2008.08.29 29日下午第五主会场:癌痛规范化处理专题研讨会

第五主会场(Simultaneous Main Session, No.5)癌痛规范化处理专题研讨会(GPM Symposium)团体会员协办(Coadjutant):北京萌蒂制药有限公司地点(Place):上海光大会展中心1楼光韵1号厅执行主席(Co-Chairs):徐建国教授 于世英

2008.08.29 29日下午第六主会场:恶性黑色素瘤专题论坛

第六主会场(Simultaneous Main Session, No.6)恶性黑色素瘤专题论坛(Melanoma Symposium)团体会员协办(Coadjutant):先灵葆雅(中国)有限公司地点(Place):上海光大会展中心2楼光大8号厅执行主席(Co-Chairs):郭 军

2008.08.29 29日下午第七主会场:赛克勒中国医师年度奖评选报告会

第七主会场(Simultaneous Main Session, No.7)赛克勒中国医师年度奖评选报告会(( Special Education Sessions)地点(Place):上海光大会展中心2楼光大9号厅会议主席(Co-Chairs):吴孟超 院士 孙 燕 院士特邀评委嘉宾
阿德福韦酯相关低磷血症患者,换用 TAF 疗效及肾脏安全性良好

2019.10.12 阿德福韦酯相关低磷血症患者,换用 TAF 疗效及肾脏安全性良好

复查肝功均正常。 2005 年 9 月因肝功异常住院,当时查 HBsAg>250.00Iu/ml,HBeAg1449.138s/co,抗 HBe48.25s/co,抗 HBc13.33s/co,HBV DNA 定量 1.15×10^9copies/ml,给予保肝治疗后好转出院。2005 年 11 月再次因肝功异常

2019.04.22 VacChina2019疫苗行业大佬齐聚北京

G-C GmbH & Co KGlRajan George博士,总裁兼首席科学官,Akshaya Bio Inc.l 

2018.11.15 2019亚洲医药研发领袖峰会再度来袭!

】:1.Integrated Development Associates Co., Ltd(CRO);2. IBM国际商业机器(中国)有限公司(AI);3. 北京春天医药

2012.09.19 2012年冷泉港亚洲年会:合成生物学

ProductsOliver Yu, 无锡新和源Wuxi New Way Biotechnology Co. ChinaAbstract

2012.09.19 2012第四届全球制药前沿(中国)论坛

of Emerging Market,Merck & CoJingwu Zang, Senior Vice President, Head

2012.09.19 美国南加州大学(USC)精品培训课程:纵览美国FDA健康产业核心领域注册法规

Green Word Public Relations & Consultant (Beijing) Co., Ltd.地址:北京市朝阳区

2012.09.19 IEEE智能计算与生物医学仪器国际会议(EI 检索)

, co-sponsored by IEEE Tainan Section, Huazhong University of Science and Technology

2012.09.19 美国医疗展|2011年美国迈阿密国际医疗器械展(FIME 2011)

Exit & Entry Co.,Ltd邱先生 Mr. andy-ku电话

2012.09.19 2nd SHARING BEST PRACTICE WORKSHOP 第二届成功经验分享研讨会

Co., Ltd账号: 860161731208091001 Account No. : 860161731208093014Swift

2012.09.19 第十一届中国国际多肽学术会议 2010CPS

PharmaceuticalCo., Ltd, / China]Songping Liang [Hunan normal University/ China

2019.09.18 2019亚太生物医药合作峰会告示之路演集锦

famous companies such as Amy Kanghuai Biopharmaceutical (Jiangsu) Co., Ltd.,Jiangsu Jindike Biotechnology Co., Ltd.,ZhongchongXinnuo Biotechnology (Taizhou

2012.09.19 【免注册费】上海分子流行病学与GWAS会议国际研讨会

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析(GWAS)为全面系统研究复杂疾病的遗传因素掀开了新的一页,为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因,我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目,吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员,特别是广大研究生了解GWAS的研究原理和方法,学会设计GWAS的研究和分析实验结果,同时在癌症领域分享海内外研究专家们的成功经验,并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加,请有意者及时将回执返回联系邮箱。免注册费(食宿餐饮费用自理)。名额有限,报名从速!时间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆 上海市邯郸路220号,200433
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹 高歌 联系电话: 021-55664495
回执邮箱: GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时  间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹,高歌 (Shanghai, China);Tamara Adams (U.S.)
联系电话: 21-55664495 (Shanghai, China);336-713-7532 (U.S.)
回执邮箱: GWAS2009@gmail.com (Shanghai, China);tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer
检验案例:警惕ELISA检测梅毒抗体中的假阴性

2016.11.13 检验案例:警惕ELISA检测梅毒抗体中的假阴性

S/CO≥1,初步判定为阳性,挑出后用 TPPA 进行确认,同时做 TRUST 检测滴度。如果 TPPA 为阳性,报梅毒抗体阳性和 TRUST 滴度,如果 TPPA 为阴性,报梅毒抗体阴性。而 S/CO<1,直接就按阴性标本发送结果。虽然,WB 才是梅毒螺旋体抗体的确认实验,但在临床工作中这项工作很难开展,而 TPPA
上一页 1 2 3 ... 10 11 12 ... 48 49 50 下一页 到第